Abstract Purpose of this Review This review assesses the latest evidence linking short-chain
fatty acids (SCFA) with host metabolic health and cardiovascular disease (CVD) risk and …

Butyrate, a main product of gut microbial fermentation, has been recognized as an important
mediator of gut microbiota regulation in whole body energy homeostasis. However, the …

Worldwide obesity is a public health concern that has reached pandemic levels. Obesity is
the major predisposing factor to comorbidities, including type 2 diabetes, cardiovascular …

A key metabolic activity of the gut microbiota is the fermentation of non-digestible
carbohydrate, which generates short-chain fatty acids (SCFAs) as the principal end …

Nondigestible carbohydrates (NDCs) are fermentation substrates in the colon after escaping
digestion in the upper gastrointestinal tract. Among NDCs, resistant starch is not hydrolyzed …

Increased dietary fiber consumption has been associated with many beneficial effects,
including amelioration of obesity and insulin resistance. These effects may be due to the …

Emerging evidence suggests that gut microbiota is critical in the maintenance of
physiological homeostasis. This study was designed to test the hypothesis that dysbiosis in …

Evidence is increasing that disturbances in the gut microbiome may play a significant role in
the etiology of obesity and type 2 diabetes. The short chain fatty acid butyrate, a major end …

Short chain fatty acids (SCFAs), mainly including acetate, propionate and butyrate, are
produced by intestinal bacteria during the fermentation of partially digested and indigestible …

AIM To investigate whether gut microbiota metabolite sodium butyrate (NaB) is an effective
substance for attenuating non-alcoholic fatty liver disease (NAFLD) and the internal …